Drivers of press media response to healthcare-associated infections caused by multidrug-resistant organisms: A report from Brazil

• Published in: Infection control and hospital epidemiology Vol. 41; no. 3; pp. 372 - 373
• Main Authors: de Azevedo Carazatto, Priscila Zacarias, Calil, Felipe Francischeti, Fortaleza, Carlos Magno Castelo Branco
• Format: Journal Article
• Language: English
• Published: United States Cambridge University Press 01.03.2020
• Subjects: Acinetobacter baumannii - drug effects; Antimicrobial agents; Brazil; Carbapenems; Consumer protection; CRE bacteria; Cross Infection - drug therapy; Cross Infection - epidemiology; Cross Infection - microbiology; Disease control; Drug resistance; Drug Resistance, Multiple, Bacterial; Drug stores; Enterobacteriaceae - drug effects; Epidemiology; Gram-Negative Bacterial Infections - drug therapy; Gram-Negative Bacterial Infections - epidemiology; Health Policy; Humans; Infections; Mass Media; Multidrug resistant organisms; Perceptions; Prevention; Public health; Public policy; Surveillance; Brazil
• ISSN: 0899-823X; 1559-6834; 1559-6834
• DOI: 10.1017/ice.2020.17

The number of articles was then analyzed considering national surveillance data. Because we were interested in the “exposure of readers” to the subject, we did not exclude articles with overlapped or partially duplicated information. In the last report of the Brazilian Program for Infection Control (data from year 2015, available at http://portal.anvisa.gov.br/documents/33852/3074203), CRAB and CRE accounted for 8.2% and 9.1% of 22,499 etiological agents of central line-associated bloodstream infections (CLABSIs). [...]a hypothetical rate of the relation between “articles in the period 2006–2018” and “number of CLABSI cases” in 2015 is 4.90 (CRAB) and 37.24 (CRE) articles per 1,000 CLABSI cases. [...]in those years, the first demands for public disclosure of individual hospitals’ HAI rates were made by consumer protection organizations.